Miriam Echaide

8PUBLICATIONS
19CO-AUTHORS
Proteins and peptidesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Agricultural molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 10, 2024
Fractalkine in Health and Disease.

Claudia Rodriguez, Luisa Chocarro, Miriam Echaide

|Jun 28, 2023
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer.

Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio

|Jun 27, 2023
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.

Ana Bocanegra, Gonzalo Fernández-Hinojal, Daniel Ajona

|Mar 29, 2023
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats.

Miriam Echaide, Luisa Chocarro de Erauso, Ana Bocanegra

|Feb 11, 2023
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors.

Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio

|Sep 23, 2022
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.

Miriam Echaide, Ibone Labiano, Marina Delgado

Pageof 2

Frequent Collaborators

8 joint publications

David Escors

7 joint publications

Ester Blanco

6 joint publications

Ana Bocanegra

6 joint publications

Luisa Chocarro